European Research Initiative on CLL


ERIC is a European organization devoted to improving the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.

There are many more open questions and new drugs available for the treatment of CLL than there are study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is essential.

ERIC is a Working Party of the European LeukemiaNet and a Scientific Working Group of the European Hematology Association. ERIC is open to all physicians and scientists working or interested in the field of chronic lymphocytic leukemia and related disorders.